Tirzepatide is a dual GIP and GLP-1 receptor agonist studied for its activity across two incretin pathways. It is used as a reference compound in metabolic and receptor signalling research in vitro.
- Dual agonist at GLP-1 and GIP receptors with partial glucagon receptor activity
- Used in pancreatic beta cell, hepatocyte and adipocyte models
- Applied in receptor binding and second messenger assays
- Reference compound for integrated incretin signalling studies
- Purity confirmed by RP-HPLC, identity by mass spectrometry
Research profile: Tirzepatide: structure, mechanism and research use






